camptothecin has been researched along with Chronic Hepatitis B in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, R; Dong, Y; Fan, H; Gu, J; Jia, Y; Li, Y; Liu, C; Ma, X; Miao, R; Niu, W; Qu, K; Ren, L; Wang, H; Wang, Z; Zhang, J; Zhang, X | 1 |
1 other study(ies) available for camptothecin and Chronic Hepatitis B
| Article | Year |
|---|---|
Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization.
Topics: Alanine Transaminase; Alkaline Phosphatase; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Camptothecin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Female; Fluorouracil; gamma-Glutamyltransferase; Hepatectomy; Hepatitis B, Chronic; Humans; Hypertension, Portal; Leukocyte Count; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Monocytes; Neoplasm Staging; Neutrophils; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tumor Burden | 2019 |